The first depression health economic modeling study, led by Professor Shirley Li Xue, from the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), revealed that Hong Kong will face a significant and ongoing burden of depression from 2023 to 2032. While fewer than 20% of the cases are expected to develop treatment-resistant depression (TRD) or related comorbidities, this group is expected to account for close to half of depression-related medical costs in the city.
This article was originally published on MedicalXpress.com